1. Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
   Xingchun Gao et al, 2017, Front. Immunol. CrossRef
2. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent
   Jianwei Zhu et al, 2017 CrossRef
3. Cytokine-induced killer (CIK) cells: from basic research to clinical translation
   Yelei Guo et al, 2015, Chin J Cancer CrossRef
4. Circulating tumor cell as a biomarker for evaluating allogenic NK cell immunotherapy on stage IV non-small cell lung cancer
   Mao Lin et al, 2017, Immunology Letters CrossRef
5. Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer.
   Shuai Wang et al, 2015, Int. Immunopharmacol. CrossRef
6. Metal Drugs and the Anticancer Immune Response
   Bernhard Englinger et al, 2018, Chem. Rev. CrossRef
7. The efficacy and safety of immunotherapy in patients with advanced NSCLC: a systematic review and meta-analysis
   Liang Zhou et al, 2016, Sci Rep CrossRef
8. The application of nano-enrichment in CTC detection and the clinical significance of CTCs in non-small cell lung cancer (NSCLC) treatment.
   Tengteng Wei et al, 2019, PLoS One CrossRef
9. Docetaxel enhances CD3+ CD56+ cytokine-induced killer cells-mediated killing through inducing tumor cells phenotype modulation
   WenJia Wang et al, 2015, Biomedicine & Pharmacotherapy CrossRef
10. Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer
    Qiu-Zhong Pan et al, 2015, OncoImmunology CrossRef
11. The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors
    Ying Wang et al, 2015, Exp Hematol Oncol CrossRef
12. Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Floris Dammeijer et al, 2016, JCO CrossRef
13. Adoptive Immunotherapy in Postoperative Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Yuan Zeng et al, 2016, PLoS ONE CrossRef
14. null
    I. Truxova et al, 2017 CrossRef
15. Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas
    Je Il Ryu et al, 2017, Immunotherapy CrossRef
16. Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer
    Mao Lin et al, 2017, Immunol Res CrossRef
17. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment
    Yunqing Xie et al, 2017, World J Surg Onc CrossRef
18. Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
    Hansong Du et al, 2020, BMC Cancer CrossRef
19. Adoptive immunotherapy shows encouraging benefit on non-small cell lung cancer: a systematic review and meta-analysis
    Binghao Zhao et al, 2017, Oncotarget CrossRef
20. Chemotherapy plus dendritic cells co-cultured with cytokine-induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: A meta-analysis
    Cuiling Zhou et al, 2016, Oncotarget CrossRef
21. null
    Le Van Manh Hung et al, 2020 CrossRef
22. Effect of dendritic cell immunotherapy on distribution of dendritic cell subsets in non-small cell lung cancer
    Zhongfei Yang et al, 2018, Exp Ther Med CrossRef
23. Effect of cytokine‑induced killer cells combined with dendritic cells on the survival rate and expression of 14‑3‑3ζ and p‑Bad proteins in Lewis lung cancer cell lines
    Yang Hou et al, 2018, Oncol Lett CrossRef
24. Dendritic Cell–Based Immunotherapy: State of the Art and Beyond
    Kalijn F. Bol et al, 2016, Clin Cancer Res CrossRef
25. The Efficacy of CIK-Based Immunotherapies for Advanced Solid Tumors
    Hongjin Chu et al, 2017, Technol Cancer Res Treat CrossRef
26. null
    Doraid Alrifai et al, 2021 CrossRef
27. Recent Advances and Future Perspective of DC-Based Therapy in NSCLC
    Iris A. E. van der Hoorn et al, 2021, Front. Immunol. CrossRef
28. Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
    Sara Nava et al, 2021, IJMS CrossRef
29. Modulation of the immune response by heterogeneous monocytes and dendritic cells in lung cancer
    Iwona Kwiecień et al, 2021, WJCO CrossRef
30. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent
    Jianwei Zhu et al, 2021 CrossRef